MX2007000397A - Agente para el tratamiento o prevencion de diabetes, obesidad o arteriosclerosis. - Google Patents

Agente para el tratamiento o prevencion de diabetes, obesidad o arteriosclerosis.

Info

Publication number
MX2007000397A
MX2007000397A MX2007000397A MX2007000397A MX2007000397A MX 2007000397 A MX2007000397 A MX 2007000397A MX 2007000397 A MX2007000397 A MX 2007000397A MX 2007000397 A MX2007000397 A MX 2007000397A MX 2007000397 A MX2007000397 A MX 2007000397A
Authority
MX
Mexico
Prior art keywords
hydrogen
ester compound
alkyl
different
same
Prior art date
Application number
MX2007000397A
Other languages
English (en)
Inventor
Takashi Kawai
Noboru Furukawa
Yasuko Mera
Mutsuyoshi Matsushita
Naoto Ogawa
Chihiro Okuma
Takahiro Hata
Yukako Sumida
Original Assignee
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc
Priority claimed from PCT/JP2003/002398 external-priority patent/WO2003072532A1/ja
Publication of MX2007000397A publication Critical patent/MX2007000397A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

A saber, la invencion se refiere a: Debido a que el compuesto de la invencion, representado por la formula (1): (ver formula 1) o sus sales farmaceuticamente aceptables tienen un excelente efecto anti-diabetico, efecto anti-obesidad y efecto anti-arteriosclerosis, un medicamento que contiene el compuesto de formula (1) como ingrediente activo es util como un agente para la prevencion o tratamiento de la diabetes (especialmente diabetes melitus no dependiente de insulina), obesidad (especialmente obesidad por grasa visceral) o arteriosclerosis.
MX2007000397A 2003-02-28 2003-02-28 Agente para el tratamiento o prevencion de diabetes, obesidad o arteriosclerosis. MX2007000397A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/JP2003/002398 WO2003072532A1 (fr) 2002-02-28 2003-02-28 Compose d'esters et ses utilisation en medecine
JP2004210492 2004-07-16
US59823304P 2004-08-02 2004-08-02

Publications (1)

Publication Number Publication Date
MX2007000397A true MX2007000397A (es) 2007-03-30

Family

ID=35785082

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007000397A MX2007000397A (es) 2003-02-28 2003-02-28 Agente para el tratamiento o prevencion de diabetes, obesidad o arteriosclerosis.

Country Status (9)

Country Link
EP (2) EP1769793A4 (es)
JP (2) JPWO2006008962A1 (es)
KR (2) KR20090110928A (es)
AU (1) AU2005264301B2 (es)
BR (1) BRPI0513368A (es)
CA (1) CA2574006A1 (es)
MX (1) MX2007000397A (es)
RU (1) RU2376015C2 (es)
WO (1) WO2006008962A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04002602A (es) 2002-02-28 2004-08-11 Japan Tobacco Inc Compuestos de ester y sus usos medicos.
WO2005021486A1 (ja) 2003-08-29 2005-03-10 Japan Tobacco Inc. エステル誘導体及びその医薬用途
US8101774B2 (en) 2004-10-18 2012-01-24 Japan Tobacco Inc. Ester derivatives and medicinal use thereof
WO2008090198A1 (en) * 2007-01-25 2008-07-31 Janssen Pharmaceutica Nv Use of mtp inhibitors for increasing levels of satiety hormones
WO2012049566A1 (en) * 2010-10-14 2012-04-19 Japan Tobacco Inc. Combination therapy for use in treating diabetes
TW201705975A (zh) * 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3662566B2 (ja) * 2002-02-28 2005-06-22 日本たばこ産業株式会社 エステル化合物及びその医薬用途
MXPA04002602A (es) * 2002-02-28 2004-08-11 Japan Tobacco Inc Compuestos de ester y sus usos medicos.
WO2005021486A1 (ja) * 2003-08-29 2005-03-10 Japan Tobacco Inc. エステル誘導体及びその医薬用途

Also Published As

Publication number Publication date
AU2005264301B2 (en) 2010-07-08
EP1769793A4 (en) 2009-06-17
EP2397129A1 (en) 2011-12-21
WO2006008962A1 (ja) 2006-01-26
CA2574006A1 (en) 2006-01-26
JPWO2006008962A1 (ja) 2008-05-01
EP1769793A1 (en) 2007-04-04
RU2007105750A (ru) 2008-09-10
JP2012167110A (ja) 2012-09-06
KR20070036126A (ko) 2007-04-02
KR20090110928A (ko) 2009-10-23
RU2376015C2 (ru) 2009-12-20
AU2005264301A1 (en) 2006-01-26
BRPI0513368A (pt) 2008-05-06

Similar Documents

Publication Publication Date Title
MXPA04002602A (es) Compuestos de ester y sus usos medicos.
BG105860A (en) Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents
DE69923849D1 (de) Quinolin-2-on-derivate verwendbar als antikrebsmittel
TW200726470A (en) 6,7-unsaturated-7-carbamoylmorphinan derivatives
NZ513893A (en) Pyrimidine compounds
CA2428271A1 (en) Cyanopyrrolidine derivatives as inhibitors of dpp-iv
NZ505638A (en) Bicyclic pyrrole derivatives as MCP-1 inhibitors
MX2009003927A (es) Derivado espirocetal de tioglucosa y uso del mismo como un agente terapeutico para la diabetes.
MXPA04004500A (es) 1,4-benzodiazepinas sustituidas y usos de las mismas para tratamiento del cancer.
DE69918404D1 (de) Aminophenoxyessigsäure derivate als neuroschützende mittel
IL146319A0 (en) Quinoline derivatives as inhibitors of mek enzymes
MX9605156A (es) Inhibidor de angiogenesis.
BR9805734A (pt) Derivados de imidazolin-4-ona úteis como agentes anticancerìgenos.
HU9403475D0 (en) Fungicidal indole-derivatives
AU5301199A (en) Oxindole derivatives as growth hormone releasers
MX2008008694A (es) Compuestos conjugados de amina terapeutica-arilsulfonamida.
BG104287A (en) Halogensubstituted tetracyclic derivatives of tetrahydrofuran
MX2007000397A (es) Agente para el tratamiento o prevencion de diabetes, obesidad o arteriosclerosis.
ATE239711T1 (de) Neue allythiopyridazinderivate und verfahren zu ihrer herstellung
IL181888A0 (en) Aminoalcohol derivatives and pharmaceutical compositions containing the same
EP1219607A4 (en) INTEGRASE INHIBITORS WITH AN AROMATIC HETEROCYCLUS
AR036764A1 (es) Derivados de [[2-(amino-3,4-dioxo-1-ciclobuten-1-il)amino]alquil]-acido para el tratamiento del dolor
IL160082A0 (en) Quinoline derivatives and use thereof as antitumor agents
TW350838B (en) Quinoline derivatives
MXPA05008923A (es) Compuestos de triazol utiles en terapia.